TMO vs CRL
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Charles River Laboratories International, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | CRL |
|---|---|---|
| Price | $675.00 | $292.84 |
| Market cap | $249.58B | $14.11B |
| P/E ratio | 36.4 | — |
| ROE | 13.51% | -7.52% |
| Profit margin | 15.04% | -5.96% |
| Revenue growth | 10.50% | -2.70% |
| Dividend yield | 0.28% | — |
| Beta | 0.85 | 1.41 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs CRL in plain English
- TMO is the bigger company — about 17.7× the market cap of CRL.
- TMO earns a higher return on equity (14% vs -8%).
- TMO is growing revenue faster (10% vs -3%).
- TMO pays a dividend (0.28%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories International, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.